Key result
Left atrial enlargement predicts ~7% higher early tachyarrhythmia recurrence risk after paroxysmal AF ablation.
Why the study?
Patient characteristics and predictors of early and late recurrence of atrial tachyarrhythmia by AF type after cryoballoon ablation remain poorly defined.
Cohort (n=2,051)
Yes
Left atrial enlargement is a consistent predictor of both early and late atrial tachyarrhythmia recurrence after cryoballoon ablation across different types of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
LA enlargement may refine post-ablation recurrence risk estimates; leaves open whether size-guided strategies improve outcomes in prospective trials.
INTRODUCTION: Patient characteristics and predictors of early (ERAT) and late (LRAT) recurrence of atrial tachyarrhythmia by atrial fibrillation (AF) type after cryoballoon ablation (CBA) remain poorly defined. METHODS: Using the Korean Heart Rhythm Cryoballoon Registry (12 centers, 2018-2022), 2051 patients undergoing CBA for drug-refractory AF were stratified by AF type. ERAT was defined as atrial tachyarrhythmia within the 3-month blanking period and LRAT as recurrence beyond 3 months. Independent predictors of ERAT (all patients) and LRAT (patients without ERAT) were identified. RESULTS: ERAT occurred in 631 patients (30.8%; 17.6% in paroxysmal and 40.4% in persistent AF). Among 1420 patients without ERAT, LRAT occurred in 311 (21.9%; 16.7% paroxysmal, 27.2% persistent). In paroxysmal AF, coronary artery disease (HR 1.60; 95% CI, 1.00-2.56; p = 0.048) and LA enlargement (HR 1.07; 95% CI, 1.04-1.10; p < 0.001) predicted ERAT, whereas hypertrophic cardiomyopathy (HR 5.01; 95% CI, 2.20-11.42; p < 0.001) and LA enlargement (HR 1.04; 95% CI, 1.01-1.08; p = 0.019) predicted LRAT. In persistent AF, AF duration (HR 1.04; 95% CI, 1.02-1.06; p < 0.001) and LA enlargement (HR 1.03; 95% CI, 1.02-1.04; p < 0.001) predicted ERAT, and LA enlargement (HR 1.03; 95% CI, 1.01-1.05; p = 0.010) independently predicted LRAT. CONCLUSION: Predictors of ERAT and LRAT differed between patients with paroxysmal and those with persistent AF. LA enlargement was the most consistently shared predictor across recurrence phenotypes.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted a cohort in Drug-refractory atrial fibrillation (n=2,051). Left atrial enlargement and other patient characteristics was evaluated on Early (ERAT) and late (LRAT) recurrence of atrial tachyarrhythmia (HR 1.07, 95% CI 1.04-1.10, p=<0.001). Left atrial enlargement consistently predicted early recurrence of atrial tachyarrhythmia in paroxysmal and persistent AF after ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: